1. Home
  2. ENS vs GH Comparison

ENS vs GH Comparison

Compare ENS & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EnerSys

ENS

EnerSys

HOLD

Current Price

$157.98

Market Cap

5.4B

Sector

Technology

ML Signal

HOLD

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$112.15

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENS
GH
Founded
1991
2011
Country
United States
United States
Employees
N/A
2021
Industry
Industrial Machinery/Components
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
13.2B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
ENS
GH
Price
$157.98
$112.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
21
Target Price
$151.33
$99.48
AVG Volume (30 Days)
428.0K
1.8M
Earning Date
02-04-2026
02-19-2026
Dividend Yield
0.68%
N/A
EPS Growth
21.73
N/A
EPS
8.58
N/A
Revenue
$3,725,304,000.00
$902,569,000.00
Revenue This Year
$4.71
$35.00
Revenue Next Year
$2.75
$26.80
P/E Ratio
$18.05
N/A
Revenue Growth
6.17
30.38
52 Week Low
$76.57
$33.75
52 Week High
$156.21
$112.43

Technical Indicators

Market Signals
Indicator
ENS
GH
Relative Strength Index (RSI) 70.00 70.14
Support Level $146.66 $97.31
Resistance Level $151.43 $104.75
Average True Range (ATR) 4.02 3.83
MACD 0.28 0.26
Stochastic Oscillator 99.04 99.25

Price Performance

Historical Comparison
ENS
GH

About ENS EnerSys

EnerSys provides stored energy solutions for industrial applications. It also manufactures and distributes energy systems solutions and motive power batteries, specialty batteries, battery chargers, power equipment, battery accessories, and outdoor equipment enclosure solutions to customers. Energy Systems that combine enclosures, power conversion, power distribution, and energy storage are used in the telecommunication and broadband, utility industries, uninterruptible power supplies, and numerous applications requiring stored energy solutions. Its segments include Energy Systems, Motive Power, and Specialty.

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: